XALURITAMIG
UNII ODG03B9M4U

Substance Identification & Data

This profile provides standardized clinical and technical data for Xaluritamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ODG03B9M4U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2559056-68-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
ODG03B9M4U
CAS Registry Number
2559056-68-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
XALURITAMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12082
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Xaluritamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

XALURITAMIG

Common Names & Synonyms

IMMUNOGLOBULIN G1-SCFV-CH/G1-KAPPA, ANTI-(HOMO SAPIENS STEAP1 (STEAP FAMILY MEMBER 1, SIX TRANSMEMBRANE EPITHELIAL ANTIGEN OF THE PROSTATE 1, STEAP1 METALLOREDUCTASE) AND ANTI-(HOMO SAPIENS CD3, BISPECIFIC, TRIVALENT
XALURITAMIG [INN]
XALURITAMIG [WHO-DD]